Genomic Valley Biotech Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 246,116 compared to INR 2.987 million a year ago. Net loss was INR 3.835 million compared to net income of INR 1.606 million a year ago. Basic loss per share from continuing operations was INR 1.26 compared to basic earnings per share from continuing operations of INR 0.53 a year ago. For the full year, total revenue was INR 2.110 million compared to INR 8.606 million a year ago. Net loss was INR 5.590 million compared to net income of INR 2.859 million a year ago. Basic loss per share from continuing operations was INR 1.83 compared to basic earnings per share from continuing operations of INR 0.94 a year ago.